Related Experiment Video
Updated: Mar 2, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
[EVALUATION OF THE ASSOCIATION BETWEEN ANTIHYPERTENSIVE TREATMENT AND DEVELOPMENT OF STROKE]
Margarita Fraimovitch1, Yosef Tzvi2, Reuven Zimlichman2,3
1Meuhedet Medical Center, Bat-Yam.
Insights
This study found no single hypertension medication prevents recurrent strokes. However, combinations like diuretics with ACE inhibitors or CCB with ACE inhibitors showed preference in preventing stroke events.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Cerebrovascular disease and atherosclerosis contribute to ischemic stroke.
- Cardiovascular risk factors significantly influence stroke development.
- Understanding medication effects on stroke is crucial for patient care.
Purpose of the Study:
- To investigate the association between specific antihypertensive medications and stroke development.
- To analyze the impact of various hypertension drug classes on stroke occurrence and recurrence.
Main Methods:
- Retrospective analysis of 916 stroke patients hospitalized between 2003-2008.
- Review of patient data for cerebrovascular accident (CVA) or transient ischemic attack (TIA).
- Assessment of cardiovascular risk factors including hypertension, diabetes, dyslipidemia, renal failure, and coronary artery disease.
Main Results:
- Ischemic stroke was the most prevalent type (70.2%), followed by TIA (24.6%) and hemorrhagic stroke (5.2%).
- A discrepancy was noted between emergency room blood pressure readings and stroke type.
- No correlation was found between ER blood pressure and recurrent stroke incidence.
Conclusions:
- No single antihypertensive drug class demonstrated priority in preventing recurrent stroke events.
- Combinations of diuretics with ACE inhibitors (ACEI) and CCB with ACEI were favored over other combinations.
- Further prospective randomized studies are needed to accurately assess risk factor and medication balance for stroke prevention.
Introduction:
An ischemic stroke is an event that occurs due to cerebral vascular disease and is directly related to the degree of vascular damage. This process is associated with atherosclerosis progression and is influenced by the presence of cardiovascular risk factors.
Aims:
One of the goals of our research was to examine whether specific medications used for treating hypertension are associated with the development of strokes.
Methods:
In a retrospective study of patients who were hospitalized between the years 2003-2008 due to a cerebrovascular accident (CVA) or a transient ischemic attack (TIA), 916 cases of stroke patients were reviewed. The patients were examined for the presence of background diseases including cardiovascular risk factors (hypertension, diabetes, dyslipidemia, renal failure, coronary artery disease).
Results:
In the study, the most common stroke type was ischemic stroke (70.2%), one quarter of the patients (24.6%) suffered from TIA, and the smallest number of patients had hemorrhagic stroke (5.2%). The study demonstrated a discrepancy between the blood pressure level that was measured in the ER and the type of stroke. Also no correlation was observed between the blood pressure level measured in the ER, and the appearance of a recurring stroke.
Conclusions:
According to the analyzed data, no priority could be given to any of the six groups of drugs that treat hypertension in preventing a recurring event of stroke. However, the drug combinations of diuretics and ACEI, and that of CCB with ACEI were preferred to all other drug combinations. For more accurate assessment of the level of balance of cardiovascular risk factors and medications against the disease, it is necessary to extend the survey, as well as perform a prospective randomized study.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Atherosclerosis IV: Nursing Management

